BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 16849538)

  • 21. NCOA3, a new fusion partner for MOZ/MYST3 in M5 acute myeloid leukemia.
    Esteyries S; Perot C; Adelaide J; Imbert M; Lagarde A; Pautas C; Olschwang S; Birnbaum D; Chaffanet M; Mozziconacci MJ
    Leukemia; 2008 Mar; 22(3):663-5. PubMed ID: 17805331
    [No Abstract]   [Full Text] [Related]  

  • 22. Pediatric acute myeloid leukemia with NPM1 mutations is characterized by a gene expression profile with dysregulated HOX gene expression distinct from MLL-rearranged leukemias.
    Mullighan CG; Kennedy A; Zhou X; Radtke I; Phillips LA; Shurtleff SA; Downing JR
    Leukemia; 2007 Sep; 21(9):2000-9. PubMed ID: 17597811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fusion gene transcripts and Ig/TCR gene rearrangements are complementary but infrequent targets for PCR-based detection of minimal residual disease in acute myeloid leukemia.
    Boeckx N; Willemse MJ; Szczepanski T; van der Velden VH; Langerak AW; Vandekerckhove P; van Dongen JJ
    Leukemia; 2002 Mar; 16(3):368-75. PubMed ID: 11896540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fusion of the MORF and CBP genes in acute myeloid leukemia with the t(10;16)(q22;p13).
    Panagopoulos I; Fioretos T; Isaksson M; Samuelsson U; Billström R; Strömbeck B; Mitelman F; Johansson B
    Hum Mol Genet; 2001 Feb; 10(4):395-404. PubMed ID: 11157802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rearrangement of the MOZ gene in pediatric therapy-related myelodysplastic syndrome with a novel chromosomal translocation t(2;8)(p23;p11).
    Imamura T; Kakazu N; Hibi S; Morimoto A; Fukushima Y; Ijuin I; Hada S; Kitabayashi I; Abe T; Imashuku S
    Genes Chromosomes Cancer; 2003 Apr; 36(4):413-9. PubMed ID: 12619166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AML with translocation t(8;16)(p11;p13) demonstrates unique cytomorphological, cytogenetic, molecular and prognostic features.
    Haferlach T; Kohlmann A; Klein HU; Ruckert C; Dugas M; Williams PM; Kern W; Schnittger S; Bacher U; Löffler H; Haferlach C
    Leukemia; 2009 May; 23(5):934-43. PubMed ID: 19194466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison between karyotyping-FISH-reverse transcription PCR and RNA-sequencing-fusion gene identification programs in the detection of KAT6A-CREBBP in acute myeloid leukemia.
    Panagopoulos I; Torkildsen S; Gorunova L; Tierens A; Tjønnfjord GE; Heim S
    PLoS One; 2014; 9(5):e96570. PubMed ID: 24798186
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A case of inv(8)(p11q24) associated with acute myeloid leukemia involves the MOZ and CBP genes in a masked t(8;16).
    Chaffanet M; Mozziconacci MJ; Fernandez F; Sainty D; Lafage-Pochitaloff M; Birnbaum D; Pébusque MJ
    Genes Chromosomes Cancer; 1999 Oct; 26(2):161-5. PubMed ID: 10469454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The clinical utility of genetic testing for t(8;16)(p11;p13) in congenital acute myeloid leukemia.
    Daifu T; Kato I; Kozuki K; Umeda K; Hiramatsu H; Watanabe K; Kamiya I; Taki T; Nakahata T; Heike T; Adachi S
    J Pediatr Hematol Oncol; 2014 Jul; 36(5):e325-7. PubMed ID: 24390445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nup98-HoxA9 immortalizes myeloid progenitors, enforces expression of Hoxa9, Hoxa7 and Meis1, and alters cytokine-specific responses in a manner similar to that induced by retroviral co-expression of Hoxa9 and Meis1.
    Calvo KR; Sykes DB; Pasillas MP; Kamps MP
    Oncogene; 2002 Jun; 21(27):4247-56. PubMed ID: 12082612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. t(11;16)(q23;p13)/KMT2A-CREBBP in hematologic malignancies: presumptive evidence of myelodysplasia or therapy-related neoplasm?
    Xie W; Tang G; Wang E; Kim Y; Cloe A; Shen Q; Zhou Y; Garcia-Manero G; Loghavi S; Hu AY; Wang S; Bueso-Ramos CE; Kantarjian HM; Medeiros LJ; Hu S
    Ann Hematol; 2020 Mar; 99(3):487-500. PubMed ID: 32006151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Upregulation of Meis1 and HoxA9 in acute lymphocytic leukemias with the t(4 : 11) abnormality.
    Rozovskaia T; Feinstein E; Mor O; Foa R; Blechman J; Nakamura T; Croce CM; Cimino G; Canaani E
    Oncogene; 2001 Feb; 20(7):874-8. PubMed ID: 11314021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis.
    Wang GG; Cai L; Pasillas MP; Kamps MP
    Nat Cell Biol; 2007 Jul; 9(7):804-12. PubMed ID: 17589499
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [FGFR1 and MOZ, two key genes involved in malignant hemopathies linked to rearrangements within the chromosomal region 8p11-12].
    Pébusque MJ; Chaffanet M; Popovici C; Birnbaum D
    Bull Cancer; 2000 Dec; 87(12):887-94. PubMed ID: 11174118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The leucine twenty homeobox (LEUTX) gene, which lacks a histone acetyltransferase domain, is fused to KAT6A in therapy-related acute myeloid leukemia with t(8;19)(p11;q13).
    Chinen Y; Taki T; Tsutsumi Y; Kobayashi S; Matsumoto Y; Sakamoto N; Kuroda J; Horiike S; Nishida K; Ohno H; Uike N; Taniwaki M
    Genes Chromosomes Cancer; 2014 Apr; 53(4):299-308. PubMed ID: 24446090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HOX expression patterns identify a common signature for favorable AML.
    Andreeff M; Ruvolo V; Gadgil S; Zeng C; Coombes K; Chen W; Kornblau S; Barón AE; Drabkin HA
    Leukemia; 2008 Nov; 22(11):2041-7. PubMed ID: 18668134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of CBP rearrangements in acute myelogenous leukemia with t(8;16).
    Giles RH; Dauwerse JG; Higgins C; Petrij F; Wessels JW; Beverstock GC; Döhner H; Jotterand-Bellomo M; Falkenburg JH; Slater RM; van Ommen GJ; Hagemeijer A; van der Reijden BA; Breuning MH
    Leukemia; 1997 Dec; 11(12):2087-96. PubMed ID: 9447825
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cooperation between AlphavBeta3 integrin and the fibroblast growth factor receptor enhances proliferation of Hox-overexpressing acute myeloid leukemia cells.
    Shah CA; Bei L; Wang H; Altman JK; Platanias LC; Eklund EA
    Oncotarget; 2016 Aug; 7(34):54782-54794. PubMed ID: 27340869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein.
    Borrow J; Stanton VP; Andresen JM; Becher R; Behm FG; Chaganti RS; Civin CI; Disteche C; Dubé I; Frischauf AM; Horsman D; Mitelman F; Volinia S; Watmore AE; Housman DE
    Nat Genet; 1996 Sep; 14(1):33-41. PubMed ID: 8782817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Common gene expression signatures in t(8;21)- and inv(16)-acute myeloid leukaemia.
    Ichikawa H; Tanabe K; Mizushima H; Hayashi Y; Mizutani S; Ishii E; Hongo T; Kikuchi A; Satake M
    Br J Haematol; 2006 Nov; 135(3):336-47. PubMed ID: 16989659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.